Lipid Management Today
November 2006, Issue 2
Release
Date: November 2006
Last Updated: November 2006
Expiration Date: October 2007
Estimated time to complete this activity: 60
minutes
Target Audience
This program is recommended for nurses, nurse practitioners, physician assistants and physicians who care for patients with hyperlipidemia.
Statement of Need
Despite the publication of many studies that support the recommended therapies for lipid management, many patients in whom therapies are indicated are still not receiving them. This online CME/CE newsletter will focus on the 2006 update of the AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Vascular Disease, which were endorsed by the National Heart, Lung, and Blood Institute. In order to ensure that the most recent relevant data are presented, this issue will also discuss the latest findings of the Treating to New Targets (TNT) study, plus new lipid therapy results presented during the 2006 International Society of Atherosclerosis in Rome, Italy. This program is designed to provide nurse practitioners, physician assistants, and physicians with information they can incorporate into their daily practice.
Educational Objectives
After completing this program, you should be able to:
- Recognize the latest lipid management goals for LDL-cholesterol
- Account for the effect of triglycerides >200 mg/dL on the updated AHA/ACC Guidelines
- Incorporate dietary changes as well as physical activity and weight management to meet treatment goals
- Encourage the consumption of omega-3 fatty acids for risk reduction
- Develop personal treatment plans that aggressively lower LDL-cholesterol to the lastest recommended levels
Accreditation Statements
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the National Lipid Association and the Preventive Cardiovascular Nurses Association. The National Lipid Association is accredited by the ACCME to provide continuing medical education for physicians.
The National Lipid Association designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This program has been approved for 1.5 contact hours of continuing education (which includes 0.5 of pharmacology) by the American Academy of Nurse Practitioners. Program ID 0610378.
This program has been reviewed and is approved for a maximum of 1 hour of clinical Category I (Preapproved) CME credit by the Physician Assistant Review Panel. Approval is valid for 1 year from the issue date of November 2006. The program expires October 31, 2007. Participants may submit the self-assessment at any time during that period. This program was planned in accordance with the AAPA's CME Standards for Enduring Material Programs and for the Commercial Support of Enduring Material Programs.
Faculty
Lisa Mustone Alexander, EdD, MPH, PA-C
Associate Professor
Department of Health Care Sciences, School of Medicine and Health Sciences
George Washington University School of Medicine and Health Sciences
Assistant Dean for Community-Based Partnerships
Washington, DC
Dean Bramlet, MD, FACC, FACP, FAHA
Assistant Consulting Professor of Medicine
Duke University School of Medicine
Clinical Associate Professor of Medicine
University of Florida School of Medicine
The Heart and Lipid Institute of Florida
Tampa, FL
Carol M. Mason, ARNP, FAHA
Adult Nurse Practitioner, Clinical Instructor
USF Pre-diabetes Research & Treatment Center
Department of Family Medicine
University of South Florida College of Medicine
Tampa, FL
Disclosure Statements
It is the policy of the National Lipid Association, the American Academy of Physician Assistants, and the American Academy of Nurse Practitioners to adhere to ACCME Essential Areas, Policies, and Standards for Commercial Support in order to ensure fair balance, independence, objectivity, and scientific rigor in all sponsored activities.
Lisa Mustone Alexander has disclosed that she has received honorarium from Merck, Pfizer, and Sanofi-Aventis.
Dean Bramlet has disclosed that he has received honoraria (speaker) from Abbott, AstraZeneca, Atherotech, Kos Pharmaceuticals, Merck, Sanofi-Aventis, Sankyo, and Schering.
Carol Mason has disclosed that she has received honoraria (speaker and consultant) from AstraZeneca, Kos Pharmaceuticals, Merck/Schering-Plough and Pfizer.
Instructions for Obtaining Continuing Education Credit
To receive CE or CME credit you must:
- Review the full content of the program.
- Successfully complete the post-test (70% or higher).
- You will have two opportunities to successfully complete the program.
You can take the post-test online at http://www.nlacme.com/lipidmanagementtoday
No fee is required for participation in this activity or for processing credits.
Commercial Support
This continuing education activity is supported by an educational grant from Merck/Schering-Plough Pharmaceuticals.
Software Requirements:
|
NLA Home
